O. G. Sevindik Et Al. , "Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities," LEUKEMIA & LYMPHOMA , vol.56, no.9, pp.2552-2555, 2015
Sevindik, O. G. Et Al. 2015. Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities. LEUKEMIA & LYMPHOMA , vol.56, no.9 , 2552-2555.
Sevindik, O. G., Guc, Z., Kahraman, S., Solmaz, S. M., Katgi, A., Acar, C., ... ALACACIOĞLU, İ.(2015). Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities. LEUKEMIA & LYMPHOMA , vol.56, no.9, 2552-2555.
Sevindik, Omur Et Al. "Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities," LEUKEMIA & LYMPHOMA , vol.56, no.9, 2552-2555, 2015
Sevindik, Omur G. Et Al. "Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities." LEUKEMIA & LYMPHOMA , vol.56, no.9, pp.2552-2555, 2015
Sevindik, O. G. Et Al. (2015) . "Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities." LEUKEMIA & LYMPHOMA , vol.56, no.9, pp.2552-2555.
@article{article, author={Omur Gokmen Sevindik Et Al. }, title={Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities}, journal={LEUKEMIA & LYMPHOMA}, year=2015, pages={2552-2555} }